Page 1 | Search Results | Blood | American Society of Hematology

1-6 of 6

Sort by

Sort Order Select

Journal Articles

Supportive Care Only Versus Allogeneic Hematopoietic Cell Transplantation in Patients ≥ 60 Years with De Novo High-Risk MDS.

Uwe Platzbecker, Jürgen Finke, Rudolf Trenschel, Schaefer-Eckart Kerstin, Martin Bornhauser, Guido Kobbe, Bart L Scott, Gerhard Ehninger, Dietrich Beelen, H. J. Deeg, Ulrich Germing

Blood (2009) 114 (22): 596.

https://doi.org/10.1182/blood.V114.22.596.596

Published: 2009

Journal Articles

Antithymocyte Globuline Given as Part of the Conditioning Regimen Has No Impact On Lung Function at 1 Year After Transplantation.

Filippo Milano, MD, PhD, Margaret A. Au, H. J. Deeg, Jason Chien, MD

Blood (2009) 114 (22): 3306.

https://doi.org/10.1182/blood.V114.22.3306.3306

Published: 2009

Journal Articles

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

F. Kerbauy, M. Maris, B. Storer, D. Maloney, D. Niederwieser, E. Agura, M. Pulsipher, T. Chauncey, R. Maziarz, S. Forman, A. Langston, J. Wade, B. Scott, J. Deeg, R. Storb, B. M. Sandmaier

Blood (2005) 106 (11): 792.

https://doi.org/10.1182/blood.V106.11.792.792

Published: 2005

Journal Articles

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

H. J. Deeg, H. M. Shulman, J. E. Anderson, E. M. Bryant, T. A. Gooley, J. T. Slattery, C. Anasetti, A. Fefer, R. Storb, F. R. Appelbaum

Blood (2000) 95 (4): 1188–1194.

https://doi.org/10.1182/blood.V95.4.1188.004k38_1188_1194

Published: 2000

Journal Articles

Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs

T de Revel, FR Appelbaum, R Storb, F Schuening, R Nash, J Deeg, I McNiece, R Andrews, T Graham

Blood (1994) 83 (12): 3795–3799.

https://doi.org/10.1182/blood.V83.12.3795.3795

Published: 1994

Journal Articles

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

R Storb, RL Prentice, M Banaji, RP Witherspoon, KM Sullivan, P Stewart, JE Sanders, M Mason, K Doney, J Deeg, RA Clift, CD Buckner, FR Appelbaum, ED Thomas

Blood (1983) 61 (4): 672–675.

https://doi.org/10.1182/blood.V61.4.672.672

Published: 1983

NARROW

Supportive Care Only Versus Allogeneic Hematopoietic Cell Transplantation in Patients ≥ 60 Years with De Novo High-Risk MDS.

Antithymocyte Globuline Given as Part of the Conditioning Regimen Has No Impact On Lung Function at 1 Year After Transplantation.

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

Email alerts

ASH Publications

American Society of Hematology

Supportive Care Only Versus Allogeneic Hematopoietic Cell Transplantation in Patients ≥ 60 Years with De Novo High-Risk MDS.

Antithymocyte Globuline Given as Part of the Conditioning Regimen Has No Impact On Lung Function at 1 Year After Transplantation.

Efficacy of Nonmyeloablative Hematopoietic Cell Transplant (HCT) in Secondary Myelodysplastic Syndrome (MDS) and Its Impact on the Primary Disease.

Allogeneic and syngeneic marrow transplantation for myelodysplastic syndrome in patients 55 to 66 years of age

Effects of granulocyte colony-stimulating factor and stem cell factor, alone and in combination, on the mobilization of peripheral blood cells that engraft lethally irradiated dogs

Marrow transplantation from HLA-identical siblings for treatment of aplastic anemia: is exposure to marrow donor blood products 24 hours before high-dose cyclophosphamide needed for successful engraftment?

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only